Skip to content

A Randomized controlled trial of modified Respiratory Guixinggong in delaying the progression of Pulmonary dysfunction in patients with mild to moderate COPD

A Randomized controlled trial of modified Respiratory Guixinggong in delaying the progression of Pulmonary dysfunction in patients with mild to moderate COPD

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040168
Enrollment
Unknown
Registered
2020-11-23
Start date
2020-11-20
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Sponsors

Affiliated Hospital of Chengdu University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. patients aged 45-75 years with mild to moderate COPD in stable stage; 2. meet the diagnostic criteria: FEV1/FVC =50% after using bronchodilator, with a history of respiratory symptoms and / or risk factors exposure; 3. one month or more after acute attack treatment; 4. did not participate in other traditional exercise before being selected; 5. voluntarily participated in this study with informed consent and signed informed consent form; 6. those with clear consciousness and stable cardiopulmonary function.

Exclusion criteria

Exclusion criteria: 1. patients with chronic cough and wheezing caused by tuberculosis, fungus, tumor, irritant gas, allergy and other factors; and patients diagnosed as bronchial asthma, bronchiectasis, lung cancer, congestive heart failure, bronchiolitis obliterans, diffuse panbronchiolitis, bronchial keratosis, etc.; 2. patients with cardiovascular, urinary, digestive, blood, endocrine and other serious primary diseases and inability to cooperate with spirit, intelligence or even thinking; 3. pregnant or lactating women; 4. patients who are participating in other clinical trials; 5. researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;

Secondary

MeasureTime frame
Six-minute walk test;Six-minute walk test;Modified Medical Research Council Dyspnea Scale;BODE index;COPD assessment test (CAT);Serum C-reactive protein;Serum interleukin-8;Exhaled nitric oxide concentration;

Countries

China

Contacts

Public ContactWei, Xiao

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

252465965@qq.com+86 18980753595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026